Also, to increase the cytotoxicity of NK cells against tumor cells, a narrow-spectrum histone deacetylase inhibitor called Entinostat was used, which increased MICA expression on tumor cells and NKG2D expression in primary NK cells, even in the hypoxic environment [117]. The gene discussed is KLRK1; the disease is neoplasm.